Abstract A series of new 3-(glycinamido)-benzofuran-2-carboxamide and 3-(b-alanamido)-benzo furan-2-carboxamide derivatives (5a-o) were synthesized for the purpose of developing the new bioactive chemical entities and evaluated for their in vitro antimicrobial, anti-inflammatory and DPPH radical scavenging activities. The synthesized compounds were characterized by NMR, IR, Mass and X-ray crystallographic techniques. 
Introduction
Benzofuran is one of the most important classes of fused ring heterocyclic compounds. The benzofuran derivatives are naturally occurring and possess many biological applications [1] [2] [3] . Angelicin, Psoralen and bergapten are the examples of naturally occurring benzofuran derivatives with biological applications [4] [5] [6] (Fig. 1) . The isolation of benzofuran derivatives from natural sources is laborious and time consuming. So the synthetic chemists are interested in synthesizing the benzofuran derivatives. Numerous synthesized benzofuran derivatives were found to be biologically active [7] [8] [9] . Now a days many synthetic benzofurans are used as good inhibitor [10, 11] , antimicrobial [12] [13] [14] , anti-inflammatory [15, 16] , antiviral [17] , antioxidant [18, 19] , anti-tumour [20] , antiproliferative [21, 22] and anti-alzheimer [23] (Fig. 2) .
In skeleton modifications of the benzofurans are possible in six different positions. For example, Marriott et al. proved that benzofuran-2-carboxamide derivatives act as sigma receptors [24] and Wu et al. synthesized modified benzofuran as SIRT1 inhibitor [10] . Similarly Kirilmis et al. reported the antimicrobial activity of benzofuran-2-ethanone derivatives [14] and Xie et al. reported the anti-inflammatory activity of benzofuran-2-carboxalamide derivatives [25] .
The role of amino acid is very important in biological systems [26, 27] . Some of the well-known derivatives of amino acids such as L-Dopa and eflornithine revealed pharmaceutical applications [28] [29] [30] . The peptide based benzofuran derivatives have shown potent biological activities [31] [32] [33] . On the basis of above facts, we focused to synthesize new benzofuran-2-carboxamide derivatives (5a-o) in our laboratory. The modifications are executed at the C3 carbon of the benzofuran with glycinamide and b-alanamide unit. The synthesized compounds were thoroughly characterized, confirmed and their in vitro biological activities such as antimicrobial, antiinflammatory and DPPH scavenging activities were evaluated.
Experimental section

General consideration
Melting points were recorded on sigma melting apparatus SL111140. IR spectrum was recorded in JASCO FT-IR410 spectrometer using KBr pellet making method. 1 H NMR and 13 C NMR spectra were recorded on Bruker 300 MHz instrument in CDCl 3 with TMS as an internal standard for proton and carbon spectra. Chemical shift values are mentioned in d (ppm) and coupling constants are given in Hz. Mass spectra were recorded on Absciex 3000 LC-MS-MS. The progress of all reactions was monitored by TLC on 2 · 5 cm pre-coated silica gel 60 F254 plates of thickness of 0.25 mm (Merck). The chromatograms were visualized under UV 254-366 nm, iodine and potassium permanganate solution. The elemental analyses were recorded in vario EL III CHNS elemental analyser. The single crystal X-ray data were recorded in Bruker Kappa APEXII single crystal X-ray diffractometer (Enraf Nonlus CAD4-MV31), SAIF, IIT Madras.
Synthesis of 2-(cyanomethoxy)benzonitrile (2)
To a stirred solution of 2-hydroxy benzonitrile 1 (0.083 mol) in DMF (50 mL), potassium carbonate (0.166 mol) and 2-chloro acetonitrile (0.101 mol) were added in room temperature. The reaction mixture was refluxed to 80°C for 3 h. Then the reaction mixture was poured into ice cold water and filtered. The solid obtained was washed with minimum amount of hexane, and then dried to get compound 2.
Brown 
Synthesis of 3-amino-1-benzofuran-2-carboxamide (3)
To a solution of (2-cyanomethoxy)benzonitrile 2 (0.0632 mol) in ethanol (100 mL), KOH (0.178 mol) was added. The reaction mixture was refluxed to 75°C for 3 h, and then the reaction mixture was poured into the ice cold water and filtered. Solid obtained was dried to afford compound 3.
White To a stirred solution of 3-amino-1-benzofuran-2-carboxamide 3 (0.0227 mol) in dichloromethane (100 mL), triethylamine was added (0.0646 mol) at 0-5°C. To this mixture acid chloride (0.0267 mol) was added drop wise over 5 min. After completion of addition, the reaction was stirred at ambient temperature for 4 h. Then the reaction mixture was diluted with dichloromethane (100 mL), washed with water (2 · 50 mL) and brine solution (50 mL). The organic layer was dried over anhydrous sodium sulphate, filtered and evaporated to afford the desired product (4a and 4b). were added at ambient temperature. After 6 h, the reaction mixture was diluted with dichloromethane (50 mL), washed with water (2 · 25 mL) and brine (25 mL). The organic layer was dried over anhydrous sodium sulphate, filtered and evaporated to get the expected compound. 1H) ,), 3.53 (t, J = 6.9 Hz, 2H), 3.04 (t, J = 6.0 Hz, 2H), 2.70 (t, J = 6.0 Hz, 2H), 2.33 (t, J = 6.9 Hz, 2H). 13 
Antimicrobial assay
The synthesized compounds were studied for antimicrobial activity followed by the reported method [34] . The test organisms were overnight cultured on agar slants, incubated at 37 ± 0.5°C and 24-48 h for bacteria and fungi (37 ± 0.5°C and 36 h) respectively to get the freshly prepared cultures. The benzofuran derivatives were evaluated for antimicrobial activity by the well diffusion method. Muller Hinton Agar (MHA) media was used for bacteria and Potato dextrose agar (PDA) media was used for fungal strains respectively. After sterilization the medium was inoculated with freshly cultured bacterial strains under sterile condition i.e. under Laminar Flow. The inoculation was started when the temperature of the medium reached 40-50°C, so that test organism may not die at higher temperature. The medium inoculated with test microorganisms was transferred into the plates of 90 mm size under sterile conditions. The medium was allowed to solidify and the wells (4/-plate) of 6 mm diameter and 50 lL volume were bored on it using sterile cork borer. The solution of test compound 1000 lg/mL was prepared in DMSO and the wells bored on the medium were each filled (50 lg) with test compound using micropipette (20-200 lL) . Four wells were bored on the plates and each filled with same compound and two plates for each test compound were taken and the experiment was repeated twice. The discs of amikacin and ketoconazole were also incorporated into the medium for comparison. The plates containing test organism and test material in contact were incubated at 37 ± 0.5°C for 24 h. Identical procedure was employed for antifungal activity. However, the culture strains of fungi and the plates were incubated at 37 ± 0.2°C for 36-72 h. Inhibition of growth of test organisms (bacterial and fungal) in the presence of test material and standard was measured with the help of standard scale and the mean values of inhibition zones are shown in Table 2 .
Anti-inflammatory activity (BSA assay)
The synthesized compounds are screened for anti-inflammatory activity by using inhibition of the albumin denaturation technique with minor modification [35] . The standard drug and synthesized compounds were dissolved in minimum quantity of Dimethyl formamide (DMF) and diluted with phosphate buffer (0.2 M, PH 7.4). Final concentration of DMF in all solutions was less than 2.5%. Test solution (4 mL) containing different concentrations of drug was mixed with 1 mL of 1 mM albumin solution in phosphate buffer and incubated at 37°C in incubator for 15 min. Denaturation was induced by keeping the reaction mixture at 70°C in water bath for 15 min. After cooling, the turbidity was measured at 660 nm. Percentage of Inhibition of denaturation was calculated from control where no drug was added. The diclofenac sodium was used as standard drug. The percentage inhibition of denaturation was calculated by using the following formula:
Anti-inflammatory activity (HRBC assay)
The synthesized compounds were screened for antiinflammatory activity by using the HRBC method by following the procedure reported by Lavanya et al. [35] .
DPPH radical scavenging activity
The DPPH radical scavenging activities of the compounds were measured by the conventional method [36] .
Results and discussion
Chemistry
In the present investigation synthesis of benzofuran derivatives from 2-hydroxy benzonitrile is shown in Scheme 1 and Table 1 . In the first step, the reaction of 2-hydroxybenzonitrile with chloroacetonitrile in the presence of potassium carbonate afforded the compound 2 with 90% yield [37] . The internal cyclization of compound 2 in the presence of potassium Scheme 1 Synthetic route for benzofuran glycinamide and b-alanamide derivatives (5a-o). 
-amino benzofuran-2-carboxamide yielded 65%. Compound 4a was obtained by coupling of chloroacetyl chloride with compound 3 in 70% yield [38] . The regular nucleophilic substitution of different amines with compound 4a afforded the corresponding glycinamide based benzofuran derivatives (5a-j). Similarly compound 4b was obtained by the coupling of 3-chloropropionyl chloride with compound 3. Further the nucleophilic replacement of different amines with 4b offered the corresponding b-alanamide based benzofuran derivatives (5k-o). All the synthesized compounds were characterized by 1 H NMR, 13 C NMR, IR and Mass spectroscopies. The appearance of amide NH peak around 10 ppm and appearance of broad singlet around 5.5 ppm and 6.0 ppm indicate the presence of amide and carboxamide units in all these derivatives. The two peaks appeared around 160 ppm in 13 C NMR is due to the presence of two carbonyl Standard-diclofenac sodium Figure 4 Anti-inflammatory activity of compound 5a-o (BSA assay).
Standard-diclofenac sodium Figure 5 Anti-inflammatory activity of compound 5a-o (HRBC Assay).
functional groups. The IR spectrum also confirms the presence of the carbonyl group. In addition, compound 5o was characterized by 1D DEPT and 2D Compound 5g was confirmed by the X-ray crystallography method [39] (Fig. 3) .
Biology
Antimicrobial activity
All the synthesized compounds were tested against the microorganism. In order to determine the antimicrobial activity, the bacterial strains are chosen as Klebsiella pneumoniae (ATCC 10031), Pseudomonas aeruginosa (ATCC 10145), and Staphylococcus aureus (ATCC 11632) and the fungal strains are Candida albicans (ATCC 66027) and Aspergillus niger Standard: Ascorbic acid Figure 6 DPPH radical scavenging activity of compound 5a-o.
Biological evaluation of new benzofuran carboxamide derivatives(ATCC 16404). Amikacin and ketoconazole were used as a standard for bacterial and fungal strain respectively. The majority of the compounds were active against K. Pneumoniae, only the compounds 5c and 5d were inactive. Similarly most of the compounds were active against P. aeruginosa except the compounds 5a, 5c, 5m and 5n. Some of the compounds were active against S. aureus namely 5i, 5m, 5n and 5o. Among these compounds 5o bearing the p-fluoro benzyl group showed better inhibition than the standard. Except 5c and 5d, remaining compounds showed moderate activity against C. albicans. Especially within this series, the compounds 5g, 5l, and 5m having piperidine, morpholine and thiophene ethylene unit showed better inhibition against C. albicans. The compounds 5i and 5o bearing pyridyl ethylene and p-fluoro benzyl unit showed both bacterial and fungal activities. But all the compounds were unable to inhibit A. niger. Overall, most of the compounds are active against K. pneumonia, P. aeruginosa and C. albicans. The zone of inhibition (in mm) of different microorganisms is listed in Table 2 .
Anti-inflammatory activity (BSA assay)
All the synthesized compounds were studied for their in vitro anti-inflammatory activity by using inhibition of the albumin denaturation technique with minor modification. The activities of the compounds were checked with four different concentrations (say 50 lm, 100 lm, 300 lm, and 500 lm). Diclofenac sodium was used as a standard. All the compounds showed moderate anti-inflammatory activity. Within this series, compounds 5k and 5o having the N-methyl piperazine and p-fluorobenzyl unit showed better activities than 5d, 5f, 5l, 5m and 5n. Compounds 5l, 5m and 5n having the substitution such as morpholine, thiophene ethylene and tolyl unit showed lesser activity than other ß-alanamide derivatives. The different concentrations of compounds and their inhibitions are represented in Fig. 4. 
Anti-inflammatory activity (HRBC assay)
The synthesized compounds were studied for their antiinflammatory activity by using the HRBC method with four different concentrations of the samples (say 50 lm, 100 lm, 300 lm, and 500 lm) as same as BSA assay. The compounds showed moderate anti-inflammatory activity compared to standard diclofenac sodium. Within this series, the compounds 5d, 5e, 5k and 5l bearing p-fluoro benzyl, morpholine and Nmethyl piperazine have shown better activity than 5a, 5f, 5h and 5m and the remaining compounds showed moderate to good anti-inflammatory activity. Anti-inflammatory activities of these derivatives (5a-o) are depending upon the nature of substitution. Overall the compounds showed better % inhibitions in HRBC assay compared to BSA assay. The % inhibitions of synthesized compounds and standard are represented in Fig. 5. 
DPPH radical scavenging activity
The synthesized compounds were studied for radical scavenging activity against DPPH free radical. All the compounds showed very good radical scavenging activity. Especially the compound 5d bearing p-fluoro benzyl unit showed highest radical scavenging activity among the other compounds. These derivatives showed rich % inhibitions at high concentrations such as 100 lm, 150 lm, and 200 lm respectively. There is not much activity difference between glycinamide derivatives and ß-alanamide derivatives. Because, derivatives of both series showed almost equal scavenging activities. The % inhibition of synthesized compounds and standard is represented in Fig. 6 .
Conclusion
A series of benzofuran based glycinamides and b-alanamides were synthesized and their in vitro antimicrobial, antiinflammatory and radical scavenging activities were studied. All the synthesized compounds showed moderate activity against microorganism and radical scavenging activity. The anti-inflammatory activity of 5k and 5o was better than other compounds. This biological result reveals that these new chemical entities can be a very good starting point for drug discovery research. The development of modified benzofuran derivatives could be a lead molecule. The current research is focused to synthesize and improves the biological activity of the benzofuran derivatives based on the above results.
